false
0001817760
0001817760
2026-02-05
2026-02-05
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported):
February 5, 2026
SmartKem, Inc.
(Exact name of registrant as specified in its charter)
| Delaware |
001-42115 |
85-1083654 |
|
(State or other jurisdiction
of incorporation)
|
(Commission
File Number) |
(IRS Employer
Identification No.) |
Manchester Technology Center, Hexagon Tower
Delaunays Road, Blackley
Manchester, M9 8GQ U.K.
(Address of principal executive offices, including
zip code)
011-44-161-721-1514
(Registrant’s telephone number, including
area code)
N/A
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to
Section 12(b) of the Act:
| Title of each class |
|
Trading Symbol(s) |
|
Name of exchange on which registered |
| Common Stock, par value $0.0001 per share |
|
SMTK |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b - 2 of
the Securities Exchange Act of 1934 (§240.12b - 2 of this chapter).
Emerging growth
company x
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 1.01 Entry into a Material Definitive Agreement.
On
February 5, 2026, SmartKem, Inc. (the “Company”) entered into a debt conversion agreement (the “Debt Conversion Agreement”)
with SmartKem Limited, a wholly owned subsidiary of the Company, and a creditor (the “Creditor”), pursuant to which the Company
agreed to issue to the Creditor (i) 385,130 shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”),
at an ascribed price of $2.75 per share and (ii) pre-funded warrants (the “Pre-Funded Warrant”) to purchase 348,260 shares
of Common Stock in satisfaction of approximately $2,016,821 owed to the Creditor by SmartKem Limited.
The
Pre-Funded Warrants are immediately exercisable at an exercise price of $0.0001 per share and may be exercised at any time until the Pre-Funded
Warrants are exercised in full. The Creditor will not have the right to exercise any portion of a Pre-Funded Warrant if it (together with
its Attribution Parties (as defined in the Pre-Funded Warrant)) would beneficially own in excess of 4.99% of the number of shares of Common
Stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms
of the Pre-Funded Warrant. However, the Creditor may increase or decrease such percentage to any other percentage not in excess of 9.99%
upon notice to the Company, provided, that any increase in this limitation will not be effective until 61 days after such notice from
the Creditor to the Company.
The
foregoing descriptions of the Pre-Funded Warrant and Debt Conversion Agreement are not complete and are qualified in their entirety by
reference to the full text of the form of Pre-Funded Warrant and the form of the Debt Conversion Agreement, copies of which are filed
as Exhibits 4.1 and 10.1, respectively, to this Current Report on Form 8-K and are incorporated by reference herein.
Item 3.02. Unregistered
Sales of Equity Securities.
The information set forth
in Item 1.01 is incorporated herein by reference. The shares of Common Stock and the Pre-Funded Warrants issued pursuant to the Debt Conversion
Agreement were issued in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit No. |
|
Description |
| 4.1 |
|
Form of Pre-Funded Warrant |
| 10.1 |
|
Form of Debt Conversion Agreement |
| 99.1 |
|
Press Release, dated February 6, 2026 |
| 104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
Signature
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
SMARTKEM, INC. |
| |
|
|
| Dated: February 6, 2026 |
By: |
/s/ Barbra C. Keck |
| |
|
Barbra C. Keck |
| |
|
Chief Financial Officer |
Exhibit 99.1
 | PRESS RELEASE |
|
Smartkem Announces Significant Reduction
in Accounts Payable Through Debt Conversion Agreement
MANCHESTER, England, February 6, 2026
– Smartkem, Inc. (Nasdaq: SMTK), (“Smartkem” or the “Company”), a leader in advanced materials,
today announced that it has entered into a debt conversion agreement, pursuant to which certain outstanding accounts payable of Smartkem
were satisfied in full through the issuance of equity securities of the Company.
Under the terms of the agreement, approximately
$2.0 million of outstanding obligations owed were converted into a combination of shares of the Company’s common stock and pre-funded
warrants at an implied conversion price of $2.75 per share. Upon issuance of the securities, the obligations were fully discharged.
The transaction resulted in a significant
reduction of the Company’s accounts payable, with no cash consideration paid. The Company believes the transaction strengthens
its balance sheet by removing this obligation and is expected to result in a meaningful reduction in ongoing cash requirements.
The securities were issued in a private
transaction exempt from registration under the Securities Act of 1933, as amended, pursuant to Section 4(a)(2) thereof. The securities
have not been registered and may not be offered or sold absent registration or an applicable exemption.
About Smartkem
Smartkem is seeking to change the world
of electronics with a new class of transistors developed using its proprietary advanced semiconductor materials. Our TRUFLEX® semiconductor
polymers enable low temperature printing processes that are compatible with existing manufacturing infrastructure to deliver low-cost,
high-performance electronics. Our semiconductor platform can be used in a range of technologies including MicroLED, LCD and AMOLED, as
well as in applications in advanced computer and AI chip packaging, sensors, and logic.
Smartkem designs and develops its materials
at its research and development facility in Manchester, UK and operates a field application office in Hsinchu, Taiwan, close to collaboration
partner, The Industrial Technology Research Institute (ITRI), where it provides prototyping services. Smartkem is developing a commercial-scale
production process and Electronic Design Automation (EDA) tools to demonstrate the commercial viability of manufacturing a new generation
of displays using its materials.
The company has an extensive IP portfolio
including 141 granted patents across 17 patent families, 15 pending patents and 40 codified trade secrets.
For more information, visit the Smartkem
website or follow on LinkedIn.
Smartkem Ltd
Manchester
Technology Center, Hexagon Tower,
Delaunays Road,
Blackley, Manchester, M9 8GQ UK
+44 (0) 161 721 1514
enquiries@smartkem.com
 | PRESS RELEASE |
|
Forward-Looking Statements
All statements in this press release
that are not historical are forward-looking statements, including, among other things, the impact that the transaction will have on the
Company’s balance sheet and its ongoing cash requirements, the potential dilutive effect of the issuance of the securities in connection
with the debt conversion agreement, its market position and market opportunity, expectations and plans as to its product development,
manufacturing and sales, and relations with its partners and investors. These statements are not historical facts but rather are based
on Smartkem, Inc.'s current expectations, estimates, and projections regarding its business, operations and other similar or related
factors. Words such as "may," "will," "could," "would," "should," "anticipate,"
"predict," "potential," "continue," "expect," "intend," "plan," "project,"
"believe," "estimate," and other similar or elated expressions are used to identify these forward-looking statements,
although not all forward-looking statements contain these words. You should not place undue reliance on forward-looking statements because
they involve known and unknown risks, uncertainties, and assumptions that are difficult or impossible to predict and, in some cases,
beyond the Company's control. Actual results may differ materially from those in the forward-looking statements as a result of a number
of factors, including those described in the Company's filings with the Securities and Exchange Commission. The Company undertakes no
obligation to revise or update information in this release to reflect events or circumstances in the future, even if new information
becomes available.
Contacts
Selena Kirkwood
Head of Communications for Smartkem
s.kirkwood@smartkem.com
Smartkem Ltd
Manchester
Technology Center, Hexagon Tower,
Delaunays Road,
Blackley, Manchester, M9 8GQ UK
+44 (0) 161 721 1514
enquiries@smartkem.com